Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Neuropathic pain in adults: pharmacological management in non-specialist settings

Clinical guideline
Reference number: CG173
Published: 20 November 2013
Last updated: 22 September 2020

History

Surveillance consultation

Surveillance consultation
Comments form (MSWord 28 KB)

Published:

22 June 2017
Surveillance review proposal (PDF 548 KB)

Published:

22 June 2017

Stakeholder list updated

Stakeholder list (PDF 44 KB)

Published:

19 June 2017

Neuropathic pain - pharmacological management: GDG membership list

Neuropathic pain - pharmacological management: GDG membership list (PDF 100 KB)

Published:

20 May 2013

Neuropathic pain - pharmacological management: guideline development and consultation

Neuropathic pain - pharmacological management: guideline development and consultation
Neuropathic pain - pharmacological management: guideline development equality impact assessment (PDF 115 KB)

Published:

20 November 2013
Neuropathic pain - pharmacological management: guideline consultation comments (PDF 1.78 MB)

Published:

20 November 2013
Neuropathic pain - pharmacological management: guideline consultation information
Neuropathic pain - pharmacological management: draft guideline (PDF 2.81 MB)

Published:

18 June 2013
Neuropathic pain - pharmacological management: draft guideline appendices information
Neuropathic pain - pharmacological management: draft guideline appendices (PDF 11.95 MB)

Published:

19 June 2013
Neuropathic pain - pharmacological management: guideline development and consultation: health economic plan, review questions and search strategies
Neuropathic pain - pharmacological management: health economic plan (PDF 115 KB)

Published:

20 May 2013
Neuropathic pain - pharmacological management: clinical questions (PDF 57 KB)

Published:

20 May 2013
Neuropathic pain - pharmacological management: search strategies (PDF 103 KB)

Published:

20 May 2013
Neuropathic pain - pharmacological management: minutes of the GDG meetings
Neuropathic pain - pharmacological management: GDG 6 - 24 July 2013 (PDF 124 KB)

Published:

12 August 2013
Neuropathic pain - pharmacological management: GDG 5 - 25 & 26 April 2013 (PDF 90 KB)

Published:

30 July 2013
Neuropathic pain - pharmacological management: GDG 4 - 29 & 30 January 2013 (PDF 84 KB)

Published:

08 April 2013
Neuropathic pain - pharmacological management: GDG 3 - 28 & 29 November 2012 (PDF 86 KB)

Published:

08 April 2013
Neuropathic pain - pharmacological management: GDG 2 - 4 September 2012 (PDF 47 KB)

Published:

16 January 2013
Neuropathic pain - pharmacological management: GDG 1 - 30 July 2012 (PDF 50 KB)

Published:

11 September 2012

Neuropathic pain - pharmacological management: scope

Neuropathic pain - pharmacological management: scope (PDF 73 KB)

Published:

03 August 2012

Neuropathic pain - pharmacological management: scope consultation table

Neuropathic pain - pharmacological management: scope consultation table (PDF 330 KB)

Published:

03 August 2012

Neuropathic pain - pharmacological management: EIA form - scoping

Neuropathic pain - pharmacological management: EIA form - scoping (PDF 90 KB)

Published:

07 August 2012

Neuropathic pain - pharmacological management: scope consultation

Neuropathic pain - pharmacological management: scope consultation information
Neuropathic pain - pharmacological management: draft scope (PDF 77 KB)

Published:

11 June 2012
Neuropathic pain - pharmacological management: stakeholder list (PDF 47 KB)

Published:

20 November 2013

Neuropathic pain - pharmacological management: stakeholder list

Neuropathic pain - pharmacological management: stakeholder list (PDF 47 KB)

Published:

20 November 2013

Neuropathic pain - pharmacological management: project history 2011

Neuropathic pain - pharmacological management: project history 2011
Neuropathic pain - pharmacological management: guideline consultation information
Neuropathic pain - pharmacological management: full guideline (PDF 1.43 MB)

Published:

12 September 2011
Neuropathic pain - pharmacological management: consultation comments form (MSWord 44 KB)

Published:

06 September 2011
Neuropathic pain - pharmacological management: list of stakeholders (PDF 30 KB)

Published:

06 September 2011
Neuropathic pain - pharmacological management: list of registered stakeholders (PDF 12 KB)

Published:

21 October 2011